---
title: "DSM-Firmenich rises after it agrees to divest feed enzymes venture"
date: "2025-02-11 16:31:12"
summary: "** Amsterdam-listed shares in DSM-Firmenich gain as much as 5.5% after the Swiss-Dutch chemical manufacturer has agreed to sell its stake in a joint enzymes venture to partner Novonesis for 1.5 billion euros ($1.55 billion)** The move comes as says DSM says it seeks options to exit its animal nutrition..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Amsterdam-listed shares in DSM-Firmenich gain as much as 5.5% after the Swiss-Dutch chemical manufacturer has agreed to sell its stake in a joint enzymes venture to partner Novonesis for 1.5 billion euros ($1.55 billion)

\*\* The move comes as says DSM says it seeks options to exit its animal nutrition and health business

\*\* KBC Securities sees it as a good deal which puts DSM "well into a net cash territory," allowing the company to strengthen its consumer-oriented activities

\*\* At 0815 GMT the stock is up 3.5% to EUR 99.32

($1 = 0.9704 euros)

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3P20M5:0-dsm-firmenich-rises-after-it-agrees-to-divest-feed-enzymes-venture/)
